https://tissuepathology.com Educational and informative Fri, 10 Apr 2026 12:19:08 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/04/10/proscia-why-precision-medicine-needs-an-enterprise-digital-pathology-backbone-not-just-a-vendor/ Fri, 10 Apr 2026 12:19:08 +0000 https://tissuepathology.com/?p=24344 From the Proscia blog: How Proscia’s Concentriq platform transforms fragmented workflows into a scalable, AI-ready engine for precision medicine growth. Precision medicine is the frontier of modern oncology. Precision medicine companies are processing unprecedented molecular volumes, serving distributed health system networks, and racing to deploy AI-driven diagnostics that can meaningfully improve patient outcomes. However, the […]

The post Proscia: Why Precision Medicine Needs an Enterprise Digital Pathology Backbone, Not Just a Vendor first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/03/12/philips-expands-digital-pathology-portfolio-with-cloud-enabled-philips-intellisite-pathology-solution-on-healthsuite/ Thu, 12 Mar 2026 12:29:46 +0000 https://tissuepathology.com/?p=24282 Philips: Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows  Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their […]

The post Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2025/12/04/proscia-achieves-soc-2-type-ii-certification-strengthening-enterprise-trust/ Thu, 04 Dec 2025 13:51:20 +0000 https://tissuepathology.com/?p=24093 Compliance with independent security standards comes as Proscia accelerates digital pathology deployments at scale PHILADELPHIA – December 3, 2025 – Proscia®, a pathology AI company, has successfully completed its SOC 2 Type II audit. This milestone underscores the company’s enterprise-grade security and operational rigor, reinforcing its role as the partner of choice for large-scale digital pathology […]

The post Proscia Achieves SOC 2 Type II Certification, Strengthening Enterprise Trust first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2025/11/05/corista-challenges-and-pitfalls-navigating-interoperability-in-digital-pathology/ Wed, 05 Nov 2025 12:47:39 +0000 https://tissuepathology.com/?p=24028 From the Corista blog Digital pathology has promised a revolution in how labs, hospitals, and research centers deliver care. Whole slide imaging (WSI), AI-powered analysis, and remote collaboration are changing workflows at a pace never seen before. But there’s a catch: interoperability. For many organizations, the excitement of “going digital” quickly collides with the reality […]

The post Corista: Challenges and Pitfalls Navigating Interoperability in Digital Pathology first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2025/09/17/artificial-intelligence-in-pathology-has-its-time-come/ Wed, 17 Sep 2025 19:36:31 +0000 https://tissuepathology.com/?p=23912 Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI’s datasets from 7 million slides, perhaps most of which were from Memorial Sloan Kettering Cancer Center. Critics were quick to point out […]

The post Artificial Intelligence in Pathology – Has It’s Time Come? first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2025/08/21/pathomation-and-mindpeak-forge-strategic-partnership-to-accelerate-ai-adoption-in-digital-pathology-workflows/ Thu, 21 Aug 2025 13:20:34 +0000 https://tissuepathology.com/?p=23853 Pathomation and Mindpeak: Mindpeak’s CE-IVD certified algorithms are now fully integrated and operational within Pathomation’s trusted digital pathology platform, built for interoperability and control, enabling frictionless AI adoption in pathology workflows. Antwerp, Belgium – August 2025, Pathomation proudly announces a strategic partnership with Mindpeak, the pioneering provider of CE-IVD certified AI solutions for tissue image […]

The post Pathomation and Mindpeak Forge Strategic Partnership to Accelerate AI Adoption in Digital Pathology Workflows first appeared on Tissuepathology.com.]]>